Recent News

• 04.21.2025 - Royalty Pharma Declares Second Quarter 2025 Dividend
• 04.17.2025 - Royalty Pharma To Announce First Quarter 2025 Financial Results On May 8, 2025
• 04.08.2025 - Royalty Pharma Appoints Vlad Coric, M.D. To The Company’s Board Of Directors
• 03.27.2025 - Royalty Pharma Announces Upcoming Investor Day
• 02.27.2025 - Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference

Recent Filings

• 04.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.21.2025 - 3 Initial statement of beneficial ownership of securities
• 04.21.2025 - 3/A Initial statement of beneficial ownership of securities
• 04.11.2025 - 8-K Current report
• 04.11.2025 - ARS Annual Report to Security Holders
• 04.11.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 04.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.10.2025 - EX-99.1 EX-99.1
• 04.10.2025 - 8-K Current report
• 04.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material